F. Gallou et al. / Tetrahedron Letters 51 (2010) 1419–1422
1421
Table 2 (continued)
Entry
Ketone
Product Major isomer
Yield
>95%
Cis/trans Isomeric ratio(*)
6
25/75
(5f)
(4f)
O
NHBn
HO
HO
COOEt
COOEt
7
8
94%
95/5
(2a)
(1)
NHBn
NH2
O
NH2
>95%
73/27
(5g)
(4g)
O
NHBn
Reaction conditions: BnNH2, Ti(OiPr)4, EtOH, rt, 1 h then NaBH4, À15 °C, 1 h.
*
Ratio determined by HPLC area % at 210 nm.
above. Control experiments also showed the importance of the hy-
droxyl group to induce the hydride reduction from the opposite
face. Protection of the latter by a non-coordinating group (OTBS en-
try 5) indeed showed a ca. 10% change in the selectivity. When the
hydroxyl group was removed, the reductive amination even led to
the formation of the trans isomer preferentially in a 75/25 ratio
(entry 6).4b We finally showed that an amino group displayed the
same directing effect as the hydroxyl group and confirmed the al-
ready described lack of selectivity (73/27 cis/trans isomeric ratio,
entry 8).3a,c
In conclusion, we have designed practical and general reac-
tion conditions that allow the selective formation of cis-1,4-
aminocyclohexanols via a controlled reductive amination. The
process is simple and directly amenable to large-scale synthesis.
We are currently investigating extension to other well-defined
ring systems and their use for the formation of chiral
compounds.
(m, 3H), 1.95–1.30 (m, 8H), 1.28 (t, J = 7.7 Hz, 3 H); 13C NMR
(100 MHz, CDCl3) d 172.8, 140.8, 129.0, 128.4, 126.8, 69.1, 60.6,
55.5, 50.9, 46.2, 35.8, 28.3, 14.2; HRMS calcd for C17H25NO3 [M+]
291.18344; found 291.18171.
References and notes
1. (a) Chassaing, C. P. A.; Schroeder, J.; Ilg, T. S.; Uphoff, M.; Meyer, T. WO2009/
077527.; (b) Ferrand, S.; Glickman, F.; Leblanc, C.; Ritchie, C.; Shaw, D.; Stiefl, N.
J.; Furet, P.; Imbach, P.; Stauffer, F.; Capraro, H.-G.; Gessier, F.; Gaul, C.; Albaugh,
P. A.; Chopiuk, G. WO2008/052734.; (c) Sekiguchi, Y.; Kanuma, K.; Omodera, K.;
Sato, K.; Hayashi, M.; Yamamoto, S. WO2006/035967.; (d) Vergne, F.;
Bernardelli, P.; Lorthiois, E.; Pham, N.; Proust, E.; Oliveira, C.; Mafroud, A.-K.;
Ducrot, P.; Wrigglesworth, R.; Berlioz-Seux, F.; Coleon, F.; Chevalier, E.; Moreau,
F.; Idrissi, M.; Tertre, A.; Descours, A.; Berna, P.; Li, M. Bioorg. Med. Chem. Lett.
2004, 14, 4615–4621; (e) Mattson, R. J.; Catt, J. D.; Sloan, C. P.; Gao, Q.; Carter, R.
B.; Gentile, A.; Mahle, C. D.; Matos, F. F.; McGovern, R.; VanderMaelene, C. P.;
Yocca, F. D. Bioorg. Med. Chem. Lett. 2003, 13, 285–288; (f) Caprathe, B. W.; Jaen,
J. C.; Smith, S. J.; Wise, L. D. US4957921.; (g) Urban, F. J.; Anderson, B. G.; Stewart,
M. A.; Young, G. R. Org. Process Res. Dev. 1999, 3, 460–464; (h) Boy, K. M.; Dee,
M.; Yevich, J.; Torrente, J.; Gao, Q.; Iben, L.; Stark, A.; Mattson, R. J. Bioorg. Med.
Chem. Lett. 2004, 14, 4467–4470; (i) Xue, C.-B.; Metcalf, B.; Han, A. Q.; Robinson,
D. J.; Zheng, C.; Wang, A.; Zhang, Y. WO2005/060665.; (j) Axten, J. M.; Daines, R.
A.; Davies, D. T.; Gallagher, T. F.; Jones, G. E.; Miller, W. H.; Pearson, N. D.;
Pendrak, I. WO2004/002992.; (k) Kawai, M.; Nakamura, H.; Sakurada, I.;
Shimokawa, H.; Tanaka, H.; Matsumizu, M.; Ando, K.; Hattori, K.; Ohta, A.;
Nukui, S.; Omura, A.; Kawamura, M. Bioorg. Med. Chem. Lett. 2007, 17, 5533–
5536; (l) Xue, C.-B.; Zheng, C.; Cao, G.; Feng, H.; Xia, M.; Anand, R.; Glenn, J.;
Metcalf, B. W. US2005/125647.; (m) Hersperger, R.; Janser, P.; Miltz, W.
WO2008/101905.
2. (a) Yang, B.; Lin, W.; Krchnak, V.; Miller, M. J. Tetrahedron Lett. 2009, 50, 5879–
5883; (b) Adamo, M. F. A.; Bruschi, S. J. Org. Chem. 2007, 72, 2666–2669.
3. (a) Hutchins, R. O.; Su, W.-Y.; Sivakumar, R.; Cistone, F.; Stercho, Y. P. J. Org.
Chem. 1983, 48, 3412–3422; (b) Hutchins, R. O.; Su, W.-Y. Tetrahedron Lett. 1984,
25, 695–698; (c) Mattson, R. J.; Pham, K. M.; Leuck, D. J.; Cowen, K. A. J. Org.
Chem. 1990, 55, 2552–2554; (d) Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.;
Maryanoff, C. A.; Shah, R. D. J. Org. Chem. 1996, 61, 3849–3862.
4. (a) Cabral, S.; Hulin, B.; Kawai, M. Tetrahedron Lett. 2007, 48, 7134–7136; (b)
Gemal, A. L.; Luche, J.-L. J. Am. Chem. Soc. 1981, 103, 5454–5459.
5. Reductive aminations of carbonyl compounds with borohydride and borane
reducing agents, Baxter, E. W.; Reitz, A. B. In Organic Reactions; John Wiley &
Sons: NewYork, 2002; pp 1–714.
2. Experimental section
General procedure: To a solution of ethyl 2-(1-hydroxy-4-oxo-
cyclohexyl)acetate 1 (2.4 g, 12 mmol, 1.0 equiv) in anhydrous eth-
anol (12 mL) at room temperature were added titanium
tetraisopropoxide (4.2 mL, 15 mmol, 1.25 equiv) and benzylamine
(1.4 mL, 12 mmol, 1.0 equiv). The resulting mixture was stirred
for 1 h, cooled to ca. À15 °C, and a freshly prepared solution of so-
dium borohydride (0.23 g, 6 mmol, 2 equiv) in anhydrous ethanol
(2 mL) was added dropwise at a rate such that the temperature re-
mained at ca. À15 °C. At completion, the mixture was quenched
with water (excess), and ethyl acetate was added. Filtration
through celite and extraction gave an organic extract that was
washed with water once, and concentrated to give the crude reac-
tion mixture.
Ethyl 2-((1S*, 4S*)-4-benzylamino)-1-hydroxycyclohexyl)ace-
tate 2a (major diastereoisomer) 1H NMR (400 MHz, CDCl3) d
7.40–7.10 (m, 5H), 4.22 (q, J = 7.7 Hz, 2H), 3.85 (s, 2H), 2.55–2.45
6. Both the cis and trans isomers were prepared via the sequence showed below,
purified as described, and the stereochemistry was unambiguously determined
by extensive NMR study and subsequent derivatization to a known compound.